🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the safety, tolerability, and objective response rate (ORR) of SHR...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-10-09
Trial ID
NCT07175220
Treatments Being Tested
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Shanxi Cancer hospital
Start Date
2025-03-28
Trial ID
NCT06895928
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Chinese People's Liberation Army General Hospital
Start Date
2024-07-30
Trial ID
NCT06512051
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Affiliated Cancer Hospital of Shandong First Medical University
Start Date
2024-06-20
Trial ID
NCT06474468
Treatments Being Tested
In phase II, the main objective is to evaluate the efficacy of SHR-A2102 co...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-04-25
Trial ID
NCT06879145
Treatments Being Tested
To evaluate the efficacy and safety of SHR-A2102 for injection versus Inves...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-02-12
Trial ID
NCT06738251
The main objective of this study is to evaluate the efficacy of SHR-A2102 v...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-03-30
Trial ID
NCT07418749
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2024-05-27
Trial ID
NCT06417554
Treatments Being Tested
The main objective of this study is to evaluate the effectiveness and safet...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-11-15
Trial ID
NCT06654440
Treatments Being Tested
This is a prospective, open-label, multicenter Phase II study evaluating th...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-23
Trial ID
NCT06819319
Treatments Being Tested